Thorn Medical (THRN): Thorne Healthtech Inc NASDAQ: THRN* G...

S&P 500

US TECH 100

Dow Jones

Brent Oil

Bitcoin

Thorn Medical (THRN)

Reply Private New

Keep Last Read

Prev Next

Send PM Follow Ignore

Followers	246
Posts	49740
Boards Moderated	69
Alias Born	08/29/2007

Re: None

Sunday, 07/23/2023 1:26:08 PM

Sunday, July 23, 2023 1:26:08 PM

Thorne Healthtech Inc NASDAQ: THRN*

GoSymbol lookup
*Nasdaq FSI: *Deficient: Issuer Failed to Meet NASDAQ Continued Listing Requirements
Consumer Staples : Personal Care Products | Small Cap BlendCompany profile
Thorne HealthTech, Inc. is a science-driven wellness company that is developing solutions for a personalized approach to health and wellness. The Company’s vertically integrated brands, Thorne and Onegevity, provide actionable insights and personalized data, products and services that individuals to take a proactive approach to improve and maintain their health over their lifetime. By combining its multi-omics database, artificial intelligence (AI) and digital health content with its science-backed nutritional supplements, it delivers a total system for wellness. Thorne provides health tests, education, and products that support the optimization of health. Onegevity provides a comprehensive molecular portrait and personalized recommendations for an individual’s health, based on integrated analysis of longitudinal blood, genetics and gut microbiome profiles. It offers health tests to generate comprehensive, personalized molecular portraits for its customers.

I am writing a book, American Cars of 1958. Check often for the latest addition. https://investorshub.advfn.com/American-Cars-of-1958-37252/

Keep Last Read

Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

1D
1M
3M
6M
1Y
5Y

Detailed Quote

Recent THRN News

Form 15-12G - Securities registration termination [Section 12(g)] • Edgar (US Regulatory) • 10/26/2023 10:03:57 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/18/2023 09:01:44 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/18/2023 09:00:39 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/18/2023 08:59:36 PM
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] • Edgar (US Regulatory) • 10/18/2023 08:55:09 PM
Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments • Edgar (US Regulatory) • 10/16/2023 08:54:57 PM
L Catterton Completes Acquisition of Thorne HealthTech, Inc. • PR Newswire (US) • 10/16/2023 01:45:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/16/2023 01:15:53 PM
Form SC 14D9/A - Solicitation, recommendation statements: [Amend] • Edgar (US Regulatory) • 10/13/2023 01:05:26 PM
Form SC TO-T/A - Tender offer statement by Third Party: [Amend] • Edgar (US Regulatory) • 10/13/2023 01:02:03 PM
L Catterton and Thorne HealthTech, Inc. Announce Expiration of Tender Offer • PR Newswire (US) • 10/13/2023 12:00:00 PM
L Catterton and Thorne HealthTech, Inc. Announce Expiration of Tender Offer • PR Newswire (US) • 10/13/2023 12:00:00 PM
Form SC TO-T/A - Tender offer statement by Third Party: [Amend] • Edgar (US Regulatory) • 10/05/2023 01:01:01 PM
Form SC 14D9/A - Solicitation, recommendation statements: [Amend] • Edgar (US Regulatory) • 10/05/2023 01:00:27 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/27/2023 09:00:31 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/18/2023 08:34:12 PM
Form SC 14D9 - Solicitation, recommendation statements • Edgar (US Regulatory) • 09/14/2023 04:11:56 PM
Form SC TO-T - Tender offer statement by Third Party • Edgar (US Regulatory) • 09/14/2023 03:44:19 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/31/2023 08:03:34 PM
Form SC14D9C - Written communication relating to third party tender offer • Edgar (US Regulatory) • 08/28/2023 09:18:58 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/28/2023 12:08:53 PM

More THRN News

InvestorsHub NewsWire

FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Start posting your company's news

Only $200 per official company press release!

InvestorsHub community

Register for free to join our community of investors and share your ideas

You'll also get access to streaming quotes, interactive charts, trades, portfolio, live options flow